SWOG clinical trial number
SWOG-9312

Phase II Evaluation of Cisplatin + 5-FU + Radiation Therapy in Patients with Locally Advanced/Inoperable Bladder Cancer

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Local Bladder
Activated
10/01/1993
Closed
04/01/1998

Research committees

Genitourinary Cancer

Publication Information Expand/Collapse

2001

Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group study

MHA Hussain;TR Glass;J Forman;W Sakr;DC Smith;M Al-Sarraf;J Jones;SP Balcerzak;ED Crawford;HB Grossman Journal of Urology 165:56-61

1999

Phase II evaluation of cisplatin + 5-fluorouracil + radiation therapy in patients with locally advanced/inoperable bladder cancer. A Southwest Oncology Group study 9312.

M Hussain;E Fisher;J Forman;W Sakr;A Drelichman;S Akhter;HB Grossman;ED Crawford Proc of the American Society of Clinical Oncology 18:333a(#1281)

Other Clinical Trials

SWOG Clinical Trial Number
S2210

S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"
Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
S2200

S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2
Research Committee(s)
Genitourinary Cancer
Activated
09/19/2022
Accrual
10%
Open
Phase
SWOG Clinical Trial Number
CTSU/A031901

Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: A Randomized Phase 3 Non-Inferiority Trial
Research Committee(s)
Genitourinary Cancer
Activated
05/01/2021
Open
Phase